Background: Atypical late gadolinium enhancement (LGE) patterns are increasingly recognized in transthyretin cardiac amyloidosis (ATTR-CM), although their clinical and prognostic significance remains poorly defined. We aimed to compare the clinical, CMR, and prognostic characteristics of patients with atypical versus typical LGE patterns. Methods: This retrospective multicentre study included 103 patients with ATTR-CM who underwent CMR at the University Hospital of Padua, Italy (n=72), and Cardiocentro Ticino, Lugano, Switzerland (n=31), between 2015 and 2025. Patients were classified as having typical (subendocardial or transmural; n=75) or atypical LGE patterns (n=28, including one patient without detectable LGE). The composite endpoint was all-cause mortality or heart failure hospitalization. Prognostic associations were assessed using Kaplan–Meier analysis and univariable Cox regression. A prespecified subgroup analysis included 73 patients with NAC stage I disease. Results: Compared with typical LGE, atypical patterns were associated with lower NT-proBNP (631 vs. 1590 ng/L, p<0.001), lower indexed LV mass (74 vs. 96 g/m², p<0.001), reduced interventricular septal thickness (15 vs. 17 mm, p=0.006), higher lateral MAPSE (12.2 vs. 9.4 mm, p=0.001), and lower ECV (37% vs. 47%, p=0.001). Native T1 did not differ significantly. Over a median follow-up of 40 months, the composite endpoint occurred in 7.1% of patients with atypical LGE versus 34.7% with typical LGE (p=0.005), with a lower estimated hazard (HR 0.24, 95% CI 0.06–1.00; p=0.05). In the NAC stage I subgroup, atypical LGE was similarly associated with lower NT-proBNP and LV mass, higher lateral MAPSE, lower ECV, and less frequent RV LGE. Event rates were 8.3% versus 34.7% (p=0.020), with a lower estimated hazard (HR 0.21, 95% CI 0.05–0.91; p=0.037). Conclusions: Atypical LGE is associated with a distinct ATTR-CM phenotype characterized by less pronounced biochemical and structural abnormalities compared with typical LGE. These differences persist among patients with NAC stage I disease, suggesting that atypical LGE might identify a milder phenotype within an already early prognostic stage.
EVOLUTION OF CARDIAC MAGNETIC RESONANCE PHENOTYPES IN TRANSTHYRETIN CARDIAC AMYLOIDOSIS
LUPI, ALESSANDRO
2024/2025
Abstract
Background: Atypical late gadolinium enhancement (LGE) patterns are increasingly recognized in transthyretin cardiac amyloidosis (ATTR-CM), although their clinical and prognostic significance remains poorly defined. We aimed to compare the clinical, CMR, and prognostic characteristics of patients with atypical versus typical LGE patterns. Methods: This retrospective multicentre study included 103 patients with ATTR-CM who underwent CMR at the University Hospital of Padua, Italy (n=72), and Cardiocentro Ticino, Lugano, Switzerland (n=31), between 2015 and 2025. Patients were classified as having typical (subendocardial or transmural; n=75) or atypical LGE patterns (n=28, including one patient without detectable LGE). The composite endpoint was all-cause mortality or heart failure hospitalization. Prognostic associations were assessed using Kaplan–Meier analysis and univariable Cox regression. A prespecified subgroup analysis included 73 patients with NAC stage I disease. Results: Compared with typical LGE, atypical patterns were associated with lower NT-proBNP (631 vs. 1590 ng/L, p<0.001), lower indexed LV mass (74 vs. 96 g/m², p<0.001), reduced interventricular septal thickness (15 vs. 17 mm, p=0.006), higher lateral MAPSE (12.2 vs. 9.4 mm, p=0.001), and lower ECV (37% vs. 47%, p=0.001). Native T1 did not differ significantly. Over a median follow-up of 40 months, the composite endpoint occurred in 7.1% of patients with atypical LGE versus 34.7% with typical LGE (p=0.005), with a lower estimated hazard (HR 0.24, 95% CI 0.06–1.00; p=0.05). In the NAC stage I subgroup, atypical LGE was similarly associated with lower NT-proBNP and LV mass, higher lateral MAPSE, lower ECV, and less frequent RV LGE. Event rates were 8.3% versus 34.7% (p=0.020), with a lower estimated hazard (HR 0.21, 95% CI 0.05–0.91; p=0.037). Conclusions: Atypical LGE is associated with a distinct ATTR-CM phenotype characterized by less pronounced biochemical and structural abnormalities compared with typical LGE. These differences persist among patients with NAC stage I disease, suggesting that atypical LGE might identify a milder phenotype within an already early prognostic stage.| File | Dimensione | Formato | |
|---|---|---|---|
|
Tesi Specialistica Alessandro Lupi.pdf
Accesso riservato
Dimensione
2 MB
Formato
Adobe PDF
|
2 MB | Adobe PDF |
The text of this website © Università degli studi di Padova. Full Text are published under a non-exclusive license. Metadata are under a CC0 License
https://hdl.handle.net/20.500.12608/120708